Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Drug Delivery
Filter     Order     Display # 
Date Item Title
20 Dec 2007 InSite Vision Initiates Pivotal Phase 3 Trials for AzaSite Plus(TM)
19 Dec 2007 Cystic Fibrosis: License Agreement Boosts Development of Therapy
18 Dec 2007 Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
17 Dec 2007 Successful transdermal oxycodone clinical trial results
07 Dec 2007 Access Pharmaceuticals Demonstrates Ability To Significantly Reduce Glucose Levels in Pre-clinical Testing of
07 Dec 2007 Submission of Marketing Authorisation Application for Dapoxetine in Europe
03 Dec 2007 Starpharma Signs Collaborative Research Agreement with Stiefel Laboratories, Inc.
28 Nov 2007 Transport’s Phase 2 Data Show Single Treatment SoloVir(TM) ETS Significantly Stops Progression of Cold Sore Episode
28 Nov 2007 Zosano Pharma, Inc. Closes Enrollment in Phase 2 Trial
27 Nov 2007 Urigen Signs Licensing Agreement with Mattern for Phase II Treatment of Hypogonadism
20 Nov 2007 NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
20 Nov 2007 Hana Biosciences Initiates Marqibo Phase 2 Clinical Trial in Metastatic Malignant Uveal Melanoma
19 Nov 2007 Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis
15 Nov 2007 Oramed Pharmaceuticals Successfully Completes Animal Studies for Phase 1B Clinical Trials Of Its Oral Insulin Capsule
12 Nov 2007 Cephalon Submits Supplemental New Drug Application for FENTORA
05 Nov 2007 MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
01 Nov 2007 Debiopharm and Nanocarrier sign License and Supply Agreement for DACH-Platin Polymeric Micelle in Oncology
01 Nov 2007 BioDelivery Sciences Submits NDA For BEMA(TM) Fentanyl
31 Oct 2007 Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch in Patients with Type 1 Diabetes
29 Oct 2007 Hana Biosciences Presents Positive Preclinical Data for Three Anti-Cancer Product Candidates At the AACR-NCI-EORTC International Conference
26 Oct 2007 Aradigm Corporation Reports Initial Human Data on a Novel Approach to Treatment of Tobacco Smoking Addiction Using its AERx Essence(R) Nicotine Inhaler
26 Oct 2007 Unigene Reports Successful Completion of Oral Calcitonin Human Study
24 Oct 2007 Hana Biosciences Presents Positive Preliminary Phase 1 Clinical Data On Alocrest At the AACR-NCI-EORTC International Conference
18 Oct 2007 Flamel Technologies Announces Positive Results of a Phase I Trial of FT-105 Basal Insulin versus Lantus(R)
16 Oct 2007 Neuromed Concludes a Special Protocol Assessment (SPA) with FDA for a Pivotal Phase 3 Study on NMED-1077
13 Oct 2007 OctoPlus announces positive Phase IIa efficacy and tolerability results for Locteron in hepatitis C
09 Oct 2007 Enrollment Complete in Pivotal Phase III Trial of Medidur(TM)FA for Diabetic Macular Edema
25 Sep 2007 Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
12 Sep 2007 Phosphagenics to commence Phase 2 TPM/Insulin cinical trial
08 Sep 2007 Penwest Enters Into Research and Development Agreement With Otsuka Pharmaceutical
06 Sep 2007 AKELA Pharma Inc. announces positive results for the extension part of its Phase IIB Fentanyl TAIFUN(R) Trial
23 Aug 2007 Enrollment begins on human PK study for Medidur(TM) FA
17 Aug 2007 Inovio Biomedical partner Tripep receives approval to initiate Phase I/II study of novel vaccine for hepatitis C virus
15 Aug 2007 Altus Pharmaceuticals’ ALTU-237 Enters Phase I Clinical Trial for the Treatment of Hyperoxalurias and the Potential Prevention of Kidney Stone Formation
15 Aug 2007 Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
09 Aug 2007 Positive Phase 1b transdermal insulin clincial trial results
08 Aug 2007 MicroDose announces positive results from the QDose inhaled insulin glucose clamp study
07 Aug 2007 Apollo's trial success - needle-free drug delivery
07 Aug 2007 Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
04 Aug 2007 Hana Biosciences Initiates Marqibo(R) Phase 2 Clinical Trial in Relapsed Acute Lymphoblastic Leukemia (All)
04 Aug 2007 Unigene Initiates Oral Calcitonin Clinical Study in Humans
02 Aug 2007 Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
20 Jul 2007 Bone Medical Phase II Capsitonin(TM) (oral calcitonin)
12 Jul 2007 YM BioSciences announces secondary efficacy and safety findings in randomized Phase IIb AeroLEF(TM) trial
10 Jul 2007 Exelon(R) Patch, the first and only skin patch for the treatment of Alzheimer's disease, receives first worldwide approval in US
28 Jun 2007 SurModics and Merck Enter Ophthalmic License and Research Collaboration Agreement
26 Jun 2007 Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Company's Dermal Drug Delivery Technology
25 Jun 2007 Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin Spray at the American Diabetes Association Meeting
21 Jun 2007 Alexza Pharmaceuticals Expands Staccato(R) Migraine Product Portfolio
13 Jun 2007 CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 51 - 100 of 410

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics